Wentao Qi

926 total citations
37 papers, 673 citations indexed

About

Wentao Qi is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Wentao Qi has authored 37 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Surgery. Recurrent topics in Wentao Qi's work include Cancer Immunotherapy and Biomarkers (8 papers), Enzyme Catalysis and Immobilization (5 papers) and Colorectal and Anal Carcinomas (5 papers). Wentao Qi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Enzyme Catalysis and Immobilization (5 papers) and Colorectal and Anal Carcinomas (5 papers). Wentao Qi collaborates with scholars based in China, United States and Switzerland. Wentao Qi's co-authors include Tongcun Zhang, Nan Wang, Yunpeng Hao, Jinhua Ding, Jing Shen, Xiuxia Zhang, Xuegang Luo, Zhong-Yuan Li, Yajian Song and Dawei Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gut and Frontiers in Immunology.

In The Last Decade

Wentao Qi

36 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wentao Qi China 18 323 157 91 78 71 37 673
Xiaoshuang Liu China 17 254 0.8× 71 0.5× 88 1.0× 63 0.8× 88 1.2× 55 755
Jing Pang China 19 305 0.9× 105 0.7× 49 0.5× 131 1.7× 105 1.5× 71 954
Peng Jiang China 15 305 0.9× 139 0.9× 45 0.5× 37 0.5× 66 0.9× 88 857
Lihong Chen China 20 361 1.1× 189 1.2× 47 0.5× 147 1.9× 186 2.6× 45 980
Jin Zhao China 19 354 1.1× 218 1.4× 37 0.4× 93 1.2× 73 1.0× 67 1.1k
Faisal A. Alzahrani Saudi Arabia 20 559 1.7× 67 0.4× 43 0.5× 23 0.3× 66 0.9× 67 1.1k
Iman M. Talaat Egypt 18 294 0.9× 163 1.0× 15 0.2× 40 0.5× 95 1.3× 91 912
Juanjuan Qiu China 16 389 1.2× 124 0.8× 38 0.4× 15 0.2× 73 1.0× 35 667
Chunli Kong China 21 542 1.7× 72 0.5× 178 2.0× 185 2.4× 67 0.9× 54 1.4k

Countries citing papers authored by Wentao Qi

Since Specialization
Citations

This map shows the geographic impact of Wentao Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wentao Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wentao Qi more than expected).

Fields of papers citing papers by Wentao Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wentao Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wentao Qi. The network helps show where Wentao Qi may publish in the future.

Co-authorship network of co-authors of Wentao Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Wentao Qi. A scholar is included among the top collaborators of Wentao Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wentao Qi. Wentao Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Hao, Wentao Qi, Qin Huang, et al.. (2024). Steroid-Refractory Myocarditis Induced by Immune Checkpoint Inhibitor Responded to Infliximab: Report of Two Cases and Literature Review. Cardiovascular Toxicology. 24(11). 1174–1191. 5 indexed citations
2.
Li, Yalun, Liyan Ji, Yingqian Zhang, et al.. (2024). The combination of tumor mutational burden and T‐cell receptor repertoire predicts the response to immunotherapy in patients with advanced non–small cell lung cancer. SHILAP Revista de lepidopterología. 5(6). e604–e604. 5 indexed citations
4.
Qi, Wentao, et al.. (2023). The clinical features and prognosis of fungal pleural infection: A case series and literature review. Medicine. 102(48). e36411–e36411. 1 indexed citations
5.
Tian, Panwen, et al.. (2023). Development and validation of the CAIL prognostic score in non‐small cell lung cancer patients with malignant pleural effusion. The Clinical Respiratory Journal. 17(11). 1158–1168. 3 indexed citations
6.
Gu, Haitao, Yunhao Tang, Linglong Peng, et al.. (2023). Predictive factors on postoperative venous thromboembolism after minimally invasive colorectal cancer surgery: a retrospective observational study. BMC Surgery. 23(1). 85–85. 1 indexed citations
7.
Ma, Jingxin, et al.. (2023). Potential role of gut microbes in the efficacy and toxicity of immune checkpoints inhibitors. Frontiers in Pharmacology. 14. 1170591–1170591. 5 indexed citations
8.
Liu, Zhen, et al.. (2023). Avermectin reduces bone mineralization via the TGF-β signaling pathway in zebrafish. Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology. 272. 109702–109702. 4 indexed citations
9.
Zhang, Xiao, Zhengyang Yang, Yongbo An, et al.. (2022). Clinical benefits of PD-1/PD-L1 inhibitors in patients with metastatic colorectal cancer: a systematic review and meta-analysis. World Journal of Surgical Oncology. 20(1). 93–93. 28 indexed citations
10.
Qi, Wentao, Ge-Ge Wu, Fan Jiang, et al.. (2022). The diagnostic performance of ultrasound computer-aided diagnosis system for distinguishing breast masses: a prospective multicenter study. European Radiology. 32(6). 4046–4055. 23 indexed citations
11.
Yang, Zhengyang, Xiao Zhang, Jiale Gao, et al.. (2022). Current progress and future perspectives of neoadjuvant anti-PD-1/PD-L1 therapy for colorectal cancer. Frontiers in Immunology. 13. 1001444–1001444. 36 indexed citations
12.
Qi, Wentao, Yang Wang, Yongbo An, et al.. (2022). Rationale and design of a prospective, multicenter, cohort study on the evaluation of postoperative Venous ThromboEmbolism incidence in patients with ColoRectal Cancer (CRC-VTE trial). Translational Cancer Research. 11(5). 1406–1412. 5 indexed citations
14.
Li, Haoze, Zhengyang Yang, Jiale Gao, et al.. (2022). Incidence and Risk Factors of Surgical Complications and Anastomotic Leakage After Transanal Total Mesorectal Excision for Middle and Low Rectal Cancer. Journal of Gastrointestinal Surgery. 27(2). 373–381. 3 indexed citations
15.
Meng, Cong, Zhengyang Yang, Haoze Li, et al.. (2022). Prognostic nutrition index predicts short-term surgical complications in patients with rectal cancer after laparoscopic surgery. Frontiers in Surgery. 9. 3 indexed citations
16.
Liu, Meiling, Xiuxia Zhang, Yunpeng Hao, et al.. (2019). Protective effects of a novel probiotic strain,Lactococcus lactisML2018, in colitis:in vivoandin vitroevidence. Food & Function. 10(2). 1132–1145. 78 indexed citations
17.
Zhang, Dawei, et al.. (2014). The effects of Cordyceps sinensis phytoestrogen on estrogen deficiency-induced osteoporosis in Ovariectomized rats. BMC Complementary and Alternative Medicine. 14(1). 484–484. 26 indexed citations
18.
Feng, Jing, Shuai Liu, Sai Ma, et al.. (2014). Protective effects of resveratrol on postmenopausal osteoporosis: regulation of SIRT1-NF-κB signaling pathway. Acta Biochimica et Biophysica Sinica. 46(12). 1024–1033. 74 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026